---
document_datetime: 2026-02-03 14:54:13
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/gilenya-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: gilenya-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 11.7729951
conversion_datetime: 2026-02-04 15:12:01.635818
docling_version:
  docling-serve: 1.11.0
  docling-jobkit: 1.9.1
  docling: 2.72.0
  docling-core: 2.63.0
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.12)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Gilenya

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific information after authorisation (archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation type IA / | This was an application for a group of | 02/02/2026                          |                                          | Annex II and                    |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000323955   | variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Labelling   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|
|                     | A.ADMINISTRATIVECHANGES-A.7 Deletionofmanufacturingsitesfor an active substance,intermediate orfinishedproduct, packaging site, manufacturer responsible for batchrelease,sitewherebatchcontroltakes place,orsupplierof astartingmaterial, reagent or excipient (when mentioned in the dossier)* - Accepted B.II.c.1 Change in the specification parameters and/or limits of an excipient - B.II.c.1.a Tightening of specification limits - Accepted B.II.c.1 Change in the specification parameters and/or limits of an excipient - B.II.c.1.a Tightening of specification limits - Accepted B.II.c.1 Change in the specification  parameters and/or limits of an excipient - B.II.c.1.bAddition of a new specification parameter to the specification with its corresponding test method - Accepted B.II.c.1 Change in the specification parameters and/or limits of an excipient - B.II.c.1.b Addition of a newspecification parametertothespecificationwithits |             |

<div style=\"page-break-after: always\"></div>

|                                       | B.II.c.1 Change in the specification parameters and/or limits of an excipient - B.II.c.1.b Addition of a new specification parameter to the specification with its corresponding testmethod-Accepted B.III.1.bEuropeanPharmacopoeial TSE Certificate ofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/orexcipient-B.Il1.1.b.2New certificate for a starting material/reagent/ intermediate/orexcipientfromaneworan alreadyapprovedmanufacturer-Accepted B.III.1.bEuropeanPharmacopoeialTSE Certificate ofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/or excipient-B.II1.1.b.2 New certificateforastartingmaterial/reagent/ intermediate/orexcipientfromaneworan alreadyapprovedmanufacturer-Accepted B.III.1.bEuropeanPharmacopoeial TSE Certificateofsuitabilityforanactive substance/startingmaterial/reagent/ intermediate/orexcipient-B.Il1.1.b.3   |            |     |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000297360 | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 28/10/2025 | N/A |

<div style=\"page-break-after: always\"></div>

| B.I.b.2 Change in testprocedure for active substanceorstarting material/reagent/intermediate used in the manufacturing process of the active substance-B.1.b.2.eOther changes toa test procedure (including replacement or addition)fortheactivesubstance or a startingmaterial/intermediate-Accepted B.I.b.2Changeintestprocedureforactive substance or starting material/reagent/intermediateusedinthe manufacturingprocess of the active substance-B.1.b.2.e Other changes toa test procedure (including replacement or addition)forthe active substance or a starting material/intermediate - Accepted B.1.b.2 Change in test procedure for active substance or starting material/reagent/intermediateusedinthe manufacturing process of the active substance-B.I.b.2.e Otherchanges to a test procedure (including replacement or addition)forthe active substance or a startingmaterial/intermediate-Accepted B.I.b.2 Change in test procedure for active substanceorstarting   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| substance - B.1.b.2.e Other changes to a test procedure (including replacement or addition)forthe active substance or a startingmaterial/intermediate-Accepted  B.1.b.2 Change in test procedure for active substance or starting material/reagent/intermediateusedinthe manufacturing process of the active substance-B.I.b.2.e Other changes to a test procedure (including replacement or addition)fortheactive substance ora startingmaterial/intermediate-Accepted  B.1.b.2Changeintestprocedurefor active substanceorstarting material/reagent/intermediateusedinthe manufacturingprocessof the active substance-B.1.b.2.e Other changes to a test procedure (including replacement or addition)fortheactivesubstance ora starting material/intermediate - Accepted  B.1.b.2 Change in test procedure for active substance or starting material/reagent/intermediateused inthe manufacturingprocessoftheactive substance-B.1.b.2.e Other changes toa test procedure (including replacement or addition) for the active substance or a startingmaterial/intermediate-Accepted   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                                       | B.1.b.2Changeintestprocedurefor active substanceorstarting material/reagent/intermediateused in the manufacturingprocessoftheactive substance-B.1.b.2.e Other changesto a test procedure (including replacement or addition) for the active substance or a starting material/intermediate - Accepted B.I.b.2 Change in testprocedure for active substance or starting material/reagent/intermediateusedinthe manufacturingprocessofthe active substance-B.I.b.2.eOtherchangestoatest procedure (including replacement or addition)fortheactive substance ora startingmaterial/intermediate-Accepted B.IACTIVESUBSTANCE-B.I.zOther variation - Accepted   |            |
|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|
| Variation type II / EMA/VR/0000257758 | Thiswas an applicationfor agroup of variations. C.IHUMANANDVETERINARYMEDICINAL PRODUCTS-C.I.13 Othervariations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority - Accepted C.IHUMANANDVETERINARYMEDICINAL                                                                                                                                                                                                                                                                                                                                                                             | 04/09/2025 |

<div style=\"page-break-after: always\"></div>

|                                       | PRODUCTS - C.I.13 Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority - Accepted Updateof theRMP(version21.1)inorder to update information on pregnancy based on final results from Gilenya Pregnancy Registry (study CFTY720D2404). Update of the RMP (version 21.1) in order to update information on pregnancy based on the fingolimod Pregnancy outcomes Intensive Monitoring (PRIM) program to collect pregnancy outcomedatafromtheNovartisglobal pharmacovigilance(PV)database   |            |     |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IA / EMA/VR/0000254065 | This was an application for a group of variations. B.III.1.bEuropeanPharmacopoeial TSE Certificateofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/orexcipient-B.II1.1.b.2New certificateforastartingmaterial/reagent/ intermediate/orexcipientfromaneworan alreadyapprovedmanufacturer-Accepted B.III.1.bEuropeanPharmacopoeialTSE Certificate ofsuitabilityforan active substance/startingmaterial/reagent/ intermediate/or excipient-B.1II1.1.b.2 New certificateforastartingmaterial/reagent/                                            | 24/02/2025 | N/A |

<div style=\"page-break-after: always\"></div>

|                          | intermediate/orexcipientfromanewor an already approved manufacturer- Accepted B.IIl.1.bEuropeanPharmacopoeial TSE Certificate of suitability for an active substance/startingmaterial/reagent/ intermediate/or excipient - B.II1.1.b.3 Updated certificate from an already approved manufacturer- Accepted B.Ill.1.bEuropeanPharmacopoeialTSE Certificate of suitability for an active substance/startingmaterial/reagent/ intermediate/orexcipient-B.1I1.1.b.3 Updatedcertificatefromanalready approved manufacturer- Accepted   |             |
|--------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|
| PSUR/EMA/PSUR/0000282248 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | Maintenance |